Issuers, get 33% more new shareholders with investorHub. Learn more
Looking for more information?
Contact our responsive and friendly client services team any time.
Neurotech International Limited
Last trade: 08/06, 2:36AM
20 min delay
Talk to Neurotech International Limited directly.
Sign up to their Investor Hub for direct access to the Neurotech International Limited team, ask them questions, and see personal updates.
Neurotech International Limited (NTI) researches, designs, markets and through third party manufacturers, produces wearable neurotechnology devices to assist with neurological conditions such as autism. Neurotech's current core focus is the design, manufacturing, sale and distribution of its first product, Mente. Mente is a portable electroencephalogram (EEG) medical device that uses neurofeedback to help relax the minds of children with autism spectrum disorder.
Level 14/191 St Georges Terrace, Perth WA 6000, Australia
Earnings per share
Dividend per share
(03) 9661 0441
Level 16, 452 Flinders St
Melbourne VIC 3000